331 related articles for article (PubMed ID: 21342461)
1. Molecular insights on the biosynthesis of antitumour compounds by actinomycetes.
Olano C; Méndez C; Salas JA
Microb Biotechnol; 2011 Mar; 4(2):144-64. PubMed ID: 21342461
[TBL] [Abstract][Full Text] [Related]
2. Indolocarbazole antitumour compounds by combinatorial biosynthesis.
Salas JA; Méndez C
Curr Opin Chem Biol; 2009 Apr; 13(2):152-60. PubMed ID: 19251468
[TBL] [Abstract][Full Text] [Related]
3. On the generation of novel anticancer drugs by recombinant DNA technology: the use of combinatorial biosynthesis to produce novel drugs.
Méndez C; Salas JA
Comb Chem High Throughput Screen; 2003 Sep; 6(6):513-26. PubMed ID: 14529377
[TBL] [Abstract][Full Text] [Related]
4. Engineering the glycosylation of natural products in actinomycetes.
Salas JA; Méndez C
Trends Microbiol; 2007 May; 15(5):219-32. PubMed ID: 17412593
[TBL] [Abstract][Full Text] [Related]
5. Artificial chromosomes to explore and to exploit biosynthetic capabilities of actinomycetes.
Alduina R; Gallo G
J Biomed Biotechnol; 2012; 2012():462049. PubMed ID: 22919271
[TBL] [Abstract][Full Text] [Related]
6. Challenges and advances in genetic manipulation of filamentous actinomycetes - the remarkable producers of specialized metabolites.
Musiol-Kroll EM; Tocchetti A; Sosio M; Stegmann E
Nat Prod Rep; 2019 Sep; 36(9):1351-1369. PubMed ID: 31517370
[TBL] [Abstract][Full Text] [Related]
7. Synthetic biology of secondary metabolite biosynthesis in actinomycetes: Engineering precursor supply as a way to optimize antibiotic production.
Wohlleben W; Mast Y; Muth G; Röttgen M; Stegmann E; Weber T
FEBS Lett; 2012 Jul; 586(15):2171-6. PubMed ID: 22710162
[TBL] [Abstract][Full Text] [Related]
8. Marine actinomycetes as an emerging resource for the drug development pipelines.
Zotchev SB
J Biotechnol; 2012 Apr; 158(4):168-75. PubMed ID: 21683100
[TBL] [Abstract][Full Text] [Related]
9. Metabolic engineering of natural product biosynthesis in actinobacteria.
Bilyk O; Luzhetskyy A
Curr Opin Biotechnol; 2016 Dec; 42():98-107. PubMed ID: 27058643
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis pathways for deoxysugars in antibiotic-producing actinomycetes: isolation, characterization and generation of novel glycosylated derivatives.
Salas JA; Méndez C
J Mol Microbiol Biotechnol; 2005; 9(2):77-85. PubMed ID: 16319497
[TBL] [Abstract][Full Text] [Related]
11. Bioprospecting potential of halogenases from Arctic marine actinomycetes.
Liao L; Chen R; Jiang M; Tian X; Liu H; Yu Y; Fan C; Chen B
BMC Microbiol; 2016 Mar; 16():34. PubMed ID: 26964536
[TBL] [Abstract][Full Text] [Related]
12. Antitumor compounds from actinomycetes: from gene clusters to new derivatives by combinatorial biosynthesis.
Olano C; Méndez C; Salas JA
Nat Prod Rep; 2009 May; 26(5):628-60. PubMed ID: 19387499
[TBL] [Abstract][Full Text] [Related]
13. Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?
Rebets Y; Brötz E; Tokovenko B; Luzhetskyy A
J Ind Microbiol Biotechnol; 2014 Feb; 41(2):387-402. PubMed ID: 24127068
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel secondary metabolites encoded in actinomycete genomes through coculture.
Kim JH; Lee N; Hwang S; Kim W; Lee Y; Cho S; Palsson BO; Cho BK
J Ind Microbiol Biotechnol; 2021 Jun; 48(3-4):. PubMed ID: 33825906
[TBL] [Abstract][Full Text] [Related]
15. Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes.
Weber T; Charusanti P; Musiol-Kroll EM; Jiang X; Tong Y; Kim HU; Lee SY
Trends Biotechnol; 2015 Jan; 33(1):15-26. PubMed ID: 25497361
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic production by actinomycetes: the Janus faces of regulation.
Cundliffe E
J Ind Microbiol Biotechnol; 2006 Jul; 33(7):500-6. PubMed ID: 16463161
[TBL] [Abstract][Full Text] [Related]
17. A Two-Component regulatory system with opposite effects on glycopeptide antibiotic biosynthesis and resistance.
Alduina R; Tocchetti A; Costa S; Ferraro C; Cancemi P; Sosio M; Donadio S
Sci Rep; 2020 Apr; 10(1):6200. PubMed ID: 32277112
[TBL] [Abstract][Full Text] [Related]
18. Discovery of the leinamycin family of natural products by mining actinobacterial genomes.
Pan G; Xu Z; Guo Z; Hindra ; Ma M; Yang D; Zhou H; Gansemans Y; Zhu X; Huang Y; Zhao LX; Jiang Y; Cheng J; Van Nieuwerburgh F; Suh JW; Duan Y; Shen B
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11131-E11140. PubMed ID: 29229819
[TBL] [Abstract][Full Text] [Related]
19. Regulation of antibiotic production in Actinobacteria: new perspectives from the post-genomic era.
van der Heul HU; Bilyk BL; McDowall KJ; Seipke RF; van Wezel GP
Nat Prod Rep; 2018 Jun; 35(6):575-604. PubMed ID: 29721572
[TBL] [Abstract][Full Text] [Related]
20. Engineering of Streptomyces lividans for heterologous expression of secondary metabolite gene clusters.
Ahmed Y; Rebets Y; Estévez MR; Zapp J; Myronovskyi M; Luzhetskyy A
Microb Cell Fact; 2020 Jan; 19(1):5. PubMed ID: 31918711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
